Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (4267)	1/4/1998 10:41:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

blankmind, The report centered around men who were suffering from impotence and that there was now an available treatment. The doctor in the report mentioned that in the past it was believed impotence was a phycological problem, and that now they have recognized the majority of impotence was in fact a physicial problem ex., diabetes, vascular disease, and trama. They then displayed each products on a table and how each one was administered. They correctly described how the muse pellet was inserted into the penis. During one of the monologs you could see a doctor in his office demonstrating the product muse to a patient. No company officials were interviewed. At the end they featured a man of 40 who was suffering from impotence and that he was on the experimental pill Viagara. He reported that his sex life had been restored to normal. Overall it was a well done unbiased piece. My hat goes off to WGNX. RT

To: blankmind who wrote (4267)	1/4/1998 10:53:00 AM
From: Zebra 365	Read Replies (4) \| Respond to of 23519

To Cacaito, First call has a consensus estimate of 0.18 for Q4 of 1997 (this is on their site through AOL right now with a 12/29/97 date), by my math this is 0.18 + 0.86 = $1.04 per share for 1997 earnings. Do you have a more recent First Call estimate of 0.04 for Q4 of 1997? To All: Prazosin is an alpha-blocker sold as an oral drug under the trade name Minipres for hypertension and for prostate enlargement. (don't get confused here, the prostate and impotence are not related) Alpha blockers are vasodilators (the active ingredient in Vasomax is phentolamine, an alpha-blocker) which work in a different way than PGE-1 (alprostadil, the current MUSE drug). The combination of alprostadil and prazosin would be expected to have higher efficacy than alprostadil alone. The use of a drug, prazosin, that already FDA approved and is being prescribed for other indications, would greatly speed the FDA approval process for a new use as initial trials for safety data and side effects can be greatly reduced. If the Phosphodiesterase blocker effect (Viagra) is more potent than alprostadil, there is nothing to prevent Vivus from adding a similar drug to a MUSE system for greater effect locally and less systemic side effect. Remember, it is the delivery system, not the drug that makes VVUS unique. Zebra